ISPE Announces its 2024 ISPE Annual Meeting & Expo Keynote Speakers, Including Health Authorities and Industry Leaders Across the Globe

The 2024 Annual Meeting & Expo, ISPE’s largest event of the year, taking place 13 to 16 October in Orlando, Florida, USA, and virtually, has announced its keynote speakers.

ISPE has announced keynote speakers from leading pharmaceutical companies including Eli Lilly, Takeda, Spark Therapeutics, and Syneos Health and regulators from the US Food and Drug Administration (US FDA), European Medicines Agency (EMA), and Health Canada, for the 2024 ISPE Annual Meeting & Expo.

I look forward to joining this year’s conference to share how regulators are working together to build a global regulatory reliance capability to better enable industry quality management. This patient-centered approach means looking beyond industry GMP compliance, to quality management that helps reduce the risk of shortages and ensure the availability of needed medicines. Quality management requires updating and innovating throughout the life cycle to continuously improve products and processes. This results in more agile quality management, improved operational resilience for both regulators and industry, and increased reliability in the supply of needed medicines for patients.

Theresa Mullin, PhD

Director, Office of Strategic Programs

FDA

Mullin will provide the opening keynote presentation entitled “Enabling More Agile Pharmaceutical Quality Management: Ensuring the Availability of Medicines for Patients,” taking place Monday, 14 October. 